Displaying 1 - 20 of 320 results
Released Company Title Industry Topic
08 Sep 2019
14:00 CEST
IPSEN Ipsen and Servier announce initial Phase II/III clinical data evaluating investigational liposomal irinotecan(ONIVYDE®) as a second-line treatment for small cell lung cancer (SCLC) at the IASLC 2019 World Conference on Lung Cancer Pharmaceuticals Other subject
13 Aug 2019
18:00 CEST
IPSEN IPSEN : Déclaration des transactions sur actions propres réalisées du 05/08/2019 au 12/08/2019 Pharmaceuticals Other subject
13 Aug 2019
18:00 CEST
IPSEN IPSEN: Disclosure of transactions in own shares between 05/08/2019 and 12/08/2019 Pharmaceuticals Other subject
08 Aug 2019
18:00 CEST
IPSEN Ipsen: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company Pharmaceuticals Other subject
08 Aug 2019
18:00 CEST
IPSEN Ipsen : Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Pharmaceuticals Other subject
06 Aug 2019
18:00 CEST
IPSEN IPSEN: Disclosure of transactions in own shares between 29/07/2019 and 02/08/2019 Pharmaceuticals Other subject
06 Aug 2019
18:00 CEST
IPSEN IPSEN : Déclaration des transactions sur actions propres réalisées du 29/07/2019 au 02/08/2019 Pharmaceuticals Other subject
30 Jul 2019
18:00 CEST
IPSEN Bilan semestriel du contrat de liquidité entre IPSEN et NATIXIS ODDO BHF Pharmaceuticals Other subject
30 Jul 2019
18:00 CEST
IPSEN IPSEN : Déclaration des transactions sur actions propres réalisées du 22/07/2019 au 26/07/2019 Pharmaceuticals Other subject
30 Jul 2019
18:00 CEST
IPSEN IPSEN: Monthly Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company Pharmaceuticals Other subject
30 Jul 2019
18:00 CEST
IPSEN Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF Pharmaceuticals Other subject
30 Jul 2019
18:00 CEST
IPSEN IPSEN: Disclosure of Transactions in Own Shares Between 22/07/2019 and 26/07/2019 Pharmaceuticals Other subject
30 Jul 2019
18:00 CEST
IPSEN IPSEN: Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social Pharmaceuticals Other subject
25 Jul 2019
07:00 CEST
IPSEN Ipsen delivers strong results for the first half of 2019 with robust double-digit sales growth and improved Core Operating margin and upgrades its guidance for full year 2019 Pharmaceuticals Income
25 Jul 2019
07:00 CEST
IPSEN Ipsen enregistre des résultats solides au premier semestre 2019 avec une croissance à deux chiffres de son chiffre d’affaires et une amélioration de la marge opérationnelle des activités. Pharmaceuticals Income
23 Jul 2019
18:00 CEST
IPSEN Ipsen: Disclosure of Transactions in Own Shares Between 15/07/2019 And 19/07/2019 Pharmaceuticals Other subject
23 Jul 2019
18:00 CEST
IPSEN Ipsen : Déclaration des transactions sur actions propres réalisées du 15/07/2019 au 19/07/2019 Pharmaceuticals Other subject
16 Jul 2019
18:00 CEST
IPSEN Ipsen: Disclosure of Transactions in Own Shares Between 08/07/2019 And 12/07/2019 Pharmaceuticals Other subject
16 Jul 2019
18:00 CEST
IPSEN Ipsen : Déclaration des transactions sur actions propres réalisées du 08/07/2019 au 12/07/2019 Pharmaceuticals Other subject
09 Jul 2019
18:00 CEST
IPSEN IPSEN : Déclaration des transactions sur actions propres réalisées du 01/07/2019 au 05/07/2019 Pharmaceuticals Other subject